Cargando…
Vaccines Against SARS-CoV-2 in Psoriasis Patients on Immunosuppressive Therapy: Implications of Vaccination Nationwide Campaign on Clinical Practice in Italy
More than 12 months have passed since the World Health Organization (WHO) declared Coronavirus Disease 19 (COVID-19), caused by the SARS-CoV2 virus, to be a pandemic on 11 March 2020. The entire world scientific community agrees that at this time vaccine is the most promising weapon to combat the in...
Autores principales: | Diotallevi, Federico, Campanati, Anna, Radi, Giulia, Martina, Emanuela, Rizzetto, Giulio, Barbadoro, Pamela, D’Errico, Marcello Mario, Offidani, Annamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8480269/ https://www.ncbi.nlm.nih.gov/pubmed/34586598 http://dx.doi.org/10.1007/s13555-021-00610-z |
Ejemplares similares
-
Safety and Efficacy of Vaccines during COVID-19 Pandemic in Patients Treated with Biological Drugs in a Dermatological Setting
por: Simonetti, Oriana, et al.
Publicado: (2021) -
Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities
por: Campanati, Anna, et al.
Publicado: (2022) -
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021) -
Biological Treatments for Pediatric Psoriasis: State of the Art and Future Perspectives
por: Diotallevi, Federico, et al.
Publicado: (2022) -
Mesenchymal Stem Cells and Psoriasis: Systematic Review
por: Diotallevi, Federico, et al.
Publicado: (2022)